Eli Lilly's oral weight loss drug sees over 5,600 prescriptions in third week

Investing.com -- Eli Lilly's newly launched oral weight loss drug received 5,612 prescriptions in the United States during its third week on the market, according to analysts citing IQVIA data.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• MARA amends Texas power site purchase agreement, posts $100M deposit
• Fed’s Hammack says public’s inflation expectations could worsen